首页 > 最新文献

Indian Journal of Palliative Care最新文献

英文 中文
Using Social Constructivist Learning Theory to Unpack General Practitioners’ Learning Preferences of End-of-Life Care: A Systematically Constructed Narrative Review 运用社会建构主义学习理论解读全科医生临终关怀学习偏好:系统建构的叙事回顾
Q3 Medicine Pub Date : 2023-09-29 DOI: 10.25259/ijpc_50_2023
Shrikant Atreya, Soumitra Shankar Datta, Naveen Salins
General practitioners play a vital role in providing community-based palliative care to patients reaching end of life. In order for GPs to upgrade their skills at end-of-life care delivery, it is imperative that training programs be aligned to their learning needs and preferences. A narrative review was conducted using the electronic databases PubMed, CINAHL, PsycINFO, EMBASE, Scopus, Web of Science, and Cochrane from 01/01/1990 to 31/05/2021. 23 articles (of 10037 searched) were included for the review. Following themes were generated: Value attributed to end-of-life care learning, experience and reflection as a departure point for learning, learning as embedded in the clinical context; autonomy to decide upon their learning needs and learning preferences, learning as a transformative process; and learning as embedded in social interaction and interpretation. Training programs that are aligned to the preferences of GPs will encourage a larger clientele of GPs to access them.
全科医生在为临终病人提供基于社区的姑息治疗方面发挥着至关重要的作用。为了提高全科医生在临终关怀服务方面的技能,培训项目必须与他们的学习需求和偏好保持一致。使用PubMed、CINAHL、PsycINFO、EMBASE、Scopus、Web of Science和Cochrane等电子数据库对1990年1月1日至2021年5月31日的文献进行述评。检索到的10037篇文章中有23篇被纳入综述。产生了以下主题:生命末期护理学习的价值,作为学习出发点的经验和反思,嵌入临床环境的学习;自主决定自己的学习需求和学习偏好,将学习视为一个变革的过程;学习是嵌入在社会互动和解释中。与全科医生的偏好相一致的培训项目将鼓励更多的全科医生客户来接受培训。
{"title":"Using Social Constructivist Learning Theory to Unpack General Practitioners’ Learning Preferences of End-of-Life Care: A Systematically Constructed Narrative Review","authors":"Shrikant Atreya, Soumitra Shankar Datta, Naveen Salins","doi":"10.25259/ijpc_50_2023","DOIUrl":"https://doi.org/10.25259/ijpc_50_2023","url":null,"abstract":"General practitioners play a vital role in providing community-based palliative care to patients reaching end of life. In order for GPs to upgrade their skills at end-of-life care delivery, it is imperative that training programs be aligned to their learning needs and preferences. A narrative review was conducted using the electronic databases PubMed, CINAHL, PsycINFO, EMBASE, Scopus, Web of Science, and Cochrane from 01/01/1990 to 31/05/2021. 23 articles (of 10037 searched) were included for the review. Following themes were generated: Value attributed to end-of-life care learning, experience and reflection as a departure point for learning, learning as embedded in the clinical context; autonomy to decide upon their learning needs and learning preferences, learning as a transformative process; and learning as embedded in social interaction and interpretation. Training programs that are aligned to the preferences of GPs will encourage a larger clientele of GPs to access them.","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135193677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Validation of Total Pain Scale for Evaluation of Total Pain in Cancer Patients. 癌症患者全身疼痛量表的开发和验证。
IF 1.1 Q3 Medicine Pub Date : 2023-07-01 Epub Date: 2023-07-11 DOI: 10.25259/IJPC_256_2022
Suraj Pal Singh, Rajeev Aggarwal, Rajeev Kumar Malhotra, Varun Shekhar, Vikram Partap Singh, Sushma Bhatnagar

Objectives: Cancer pain has all the components of total pain such as physical, social, psychological, and spiritual. These components contribute to the overall pain experience in cancer patients. Many instruments have been developed till date to assess the effect of pain in cancer patients but none of the instruments include all components of total pain. In this article, we describe the development and validation of the total pain scale (TPS) for the evaluation of total pain in cancer patients with pain. This study aimed to develop and validate a questionnaire for the evaluation of total pain in cancer patients with pain.

Material and methods: This study included a review of existing pain questionnaires for cancer pain for item pool generation. Items were generated in the Hindi language by six stakeholders to create 23 items to develop TPS. TPS was applied to 300 Hindi-speaking cancer patients. Bivariate correlation was used to reduce the number of items as well as construction of the domain followed by factor analysis to finalise TPS. Confirmatory factor analysis (CFA) was performed for testing the validity and reliability of TPS.

Results: TPS is an 18-item scale composed of four domains (physical, social, spiritual and psychological domain). The internal consistency of TPS and its subscales was found to be very good (a = 0.84-0.88). CFA and structural equation modeling Goodness of fit has confirmed that model 4 is the best fit as it yielded a lesser root-mean-squared error of approximation value of 0.062 and a greater comparative fit index, Tucker-Lewis index value of 0.944. The convergent and divergent validity of TPS and its domain was good.

Conclusion: This study reports TPS to be a brief (18-item), valid, and reliable questionnaire in the Hindi language for assessment of all components of total pain in cancer patients with pain.

目的:癌症疼痛包括身体、社会、心理和精神等全部疼痛成分。这些成分有助于癌症患者的整体疼痛体验。迄今为止,已经开发了许多仪器来评估癌症患者疼痛的影响,但没有一种仪器包括完全疼痛的所有成分。在这篇文章中,我们描述了总疼痛量表(TPS)的开发和验证,用于评估癌症疼痛患者的总疼痛。本研究旨在开发和验证一份用于评估癌症疼痛患者全身疼痛的问卷。材料和方法:本研究包括对现有癌症疼痛项目库生成疼痛问卷的回顾。六个利益相关者用印地语生成了项目,创建了23个项目来开发TPS。TPS应用于300名讲印地语的癌症患者。双变量相关性用于减少项目数量以及领域构建,然后进行因子分析以最终确定TPS。结果:TPS是一个由物理、社会、精神和心理四个领域组成的18项量表。TPS及其分量表的内部一致性非常好(a=0.84-0.88)。CFA和结构方程建模拟合优度已经证实,模型4是最佳拟合,因为它产生了较小的均方根误差(近似值为0.062)和较大的比较拟合指数(Tucker Lewis指数值为0.944)。TPS及其域的收敛和发散有效性良好。结论:本研究报告TPS是一份简短(18项)、有效和可靠的印地语问卷,用于评估癌症疼痛患者全身疼痛的所有成分。
{"title":"Development and Validation of Total Pain Scale for Evaluation of Total Pain in Cancer Patients.","authors":"Suraj Pal Singh,&nbsp;Rajeev Aggarwal,&nbsp;Rajeev Kumar Malhotra,&nbsp;Varun Shekhar,&nbsp;Vikram Partap Singh,&nbsp;Sushma Bhatnagar","doi":"10.25259/IJPC_256_2022","DOIUrl":"10.25259/IJPC_256_2022","url":null,"abstract":"<p><strong>Objectives: </strong>Cancer pain has all the components of total pain such as physical, social, psychological, and spiritual. These components contribute to the overall pain experience in cancer patients. Many instruments have been developed till date to assess the effect of pain in cancer patients but none of the instruments include all components of total pain. In this article, we describe the development and validation of the total pain scale (TPS) for the evaluation of total pain in cancer patients with pain. This study aimed to develop and validate a questionnaire for the evaluation of total pain in cancer patients with pain.</p><p><strong>Material and methods: </strong>This study included a review of existing pain questionnaires for cancer pain for item pool generation. Items were generated in the Hindi language by six stakeholders to create 23 items to develop TPS. TPS was applied to 300 Hindi-speaking cancer patients. Bivariate correlation was used to reduce the number of items as well as construction of the domain followed by factor analysis to finalise TPS. Confirmatory factor analysis (CFA) was performed for testing the validity and reliability of TPS.</p><p><strong>Results: </strong>TPS is an 18-item scale composed of four domains (physical, social, spiritual and psychological domain). The internal consistency of TPS and its subscales was found to be very good (a = 0.84-0.88). CFA and structural equation modeling Goodness of fit has confirmed that model 4 is the best fit as it yielded a lesser root-mean-squared error of approximation value of 0.062 and a greater comparative fit index, Tucker-Lewis index value of 0.944. The convergent and divergent validity of TPS and its domain was good.</p><p><strong>Conclusion: </strong>This study reports TPS to be a brief (18-item), valid, and reliable questionnaire in the Hindi language for assessment of all components of total pain in cancer patients with pain.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/56/c3/IJPC-29-312.PMC10493691.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10244001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing the Role of Higher Education Institutions to Support Palliative Care Education in Primary Care and Humanitarian Settings within Low- and Middle-Income Countries: Online Workshop Report. 促进高等教育机构在中低收入国家初级保健和人道主义环境中支持姑息治疗教育的作用:在线研讨会报告。
IF 1.1 Q3 Medicine Pub Date : 2023-07-01 Epub Date: 2023-06-13 DOI: 10.25259/IJPC_45_2023
Teguh Kristian Perdamaian, Michelle McGannan, Liz Grant, David Fearon

The need for palliative care is increasing, especially in low- and middle-income countries (LMICs). Higher education institutions (HEIs) have a role to play in developing a skilled palliative care workforce in LMICs. A workshop was held to discuss this issue, and it was attended by experts from around the world. The workshop highlighted the challenges and opportunities for palliative care education in HEIs for LMIC settings. The participants discussed the importance of a collaborative interprofessional approach and advocacy for the inclusion of palliative care into a wide range of curricula. They also expressed the hope to explore possibilities of networks to continue this discussion and incorporate the wider perspectives from primary care and humanitarian practitioners.

对姑息治疗的需求正在增加,尤其是在中低收入国家。高等教育机构(HEI)在培养LMIC熟练的姑息治疗劳动力方面发挥着作用。为讨论这一问题举行了一次讲习班,来自世界各地的专家出席了讲习班。研讨会强调了在LMIC环境下高等教育机构开展姑息治疗教育的挑战和机遇。与会者讨论了跨专业合作方法和倡导将姑息治疗纳入广泛课程的重要性。他们还表示希望探索网络的可能性,以继续这一讨论,并纳入初级保健和人道主义工作者的更广泛观点。
{"title":"Advancing the Role of Higher Education Institutions to Support Palliative Care Education in Primary Care and Humanitarian Settings within Low- and Middle-Income Countries: Online Workshop Report.","authors":"Teguh Kristian Perdamaian,&nbsp;Michelle McGannan,&nbsp;Liz Grant,&nbsp;David Fearon","doi":"10.25259/IJPC_45_2023","DOIUrl":"10.25259/IJPC_45_2023","url":null,"abstract":"<p><p>The need for palliative care is increasing, especially in low- and middle-income countries (LMICs). Higher education institutions (HEIs) have a role to play in developing a skilled palliative care workforce in LMICs. A workshop was held to discuss this issue, and it was attended by experts from around the world. The workshop highlighted the challenges and opportunities for palliative care education in HEIs for LMIC settings. The participants discussed the importance of a collaborative interprofessional approach and advocacy for the inclusion of palliative care into a wide range of curricula. They also expressed the hope to explore possibilities of networks to continue this discussion and incorporate the wider perspectives from primary care and humanitarian practitioners.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7b/b6/IJPC-29-332.PMC10493692.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10221631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mapping of Palliative Care Services and Challenges in Implementation of National Program for Palliative Care in Puducherry. 普杜切里国家姑息治疗方案实施过程中的姑息治疗服务和挑战。
IF 1.1 Q3 Medicine Pub Date : 2023-07-01 Epub Date: 2023-01-18 DOI: 10.25259/IJPC_146_2022
Mayank Sharma, Sonali Sarkar, S Adinarayanan, Gunaseelan Karunanithi

Objectives: The purpose of this study was to map ongoing palliative care services and describe the characteristics of providers, recipients, level of care, and approach. Second, it seeks to investigate the difficulties encountered in implementing NPPC in the Puducherry district of UT Puducherry. This study aims to review the challenges in its implementation.

Material and methods: The study using both quantitative and qualitative design, including geospatial mapping of organisations, describing service delivery characteristics and exploring challenges faced in implementing NPPC, was conducted from July 2021 to January 2022. In-depth interviews were conducted with seven healthcare providers, four patients and three caregivers, as well as key informant interviews with six doctors in administration.

Results: Thirteen organisations providing palliative care to population of Puducherry district of union territory Puducherry and neighbouring districts of Tamil Nadu were identified. Mapped organisations were primarily concentrated in urban areas. Morphine was available only at three medical colleges, providing outpatient palliative care services. Non-governmental organisations provided only home-based palliative care services and the hospices provided both in-patient and home-based services. Key barriers perceived by the health system were difficulty in procuring morphine, inadequate personnel and inadequate funding. Few barriers perceived by patients/family were stigma faced in community, psychological challenges and poor quality of care.

Conclusions: Palliative care services are mainly available in urban areas and through private hospices. There is a need to implement palliative care program through the public health system to improve the accessibility in the rural areas.

目的:本研究的目的是绘制正在进行的姑息治疗服务图,并描述提供者、接受者、护理水平和方法的特征。其次,它试图调查在UT Puducherry的Puduchery区实施NPPC时遇到的困难。本研究旨在审查其执行过程中的挑战。材料和方法:该研究于2021年7月至2022年1月进行,采用了定量和定性设计,包括组织的地理空间地图,描述了服务提供特征,并探讨了实施NPPC面临的挑战。对七名医疗保健提供者、四名患者和三名护理人员进行了深入访谈,并对六名管理医生进行了关键线人访谈。结果:确定了13个为联邦领地普杜切里区和泰米尔纳德邦邻近地区的居民提供姑息治疗的组织。地图组织主要集中在城市地区。只有三所医学院提供吗啡,提供门诊姑息治疗服务。非政府组织只提供家庭姑息治疗服务,收容所同时提供住院和家庭服务。卫生系统认为的主要障碍是难以采购吗啡、人员不足和资金不足。患者/家庭认为的障碍很少是社区中面临的耻辱、心理挑战和护理质量差。结论:姑息治疗服务主要在城市地区和私人收容所提供。有必要通过公共卫生系统实施姑息治疗计划,以提高农村地区的可及性。
{"title":"Mapping of Palliative Care Services and Challenges in Implementation of National Program for Palliative Care in Puducherry.","authors":"Mayank Sharma,&nbsp;Sonali Sarkar,&nbsp;S Adinarayanan,&nbsp;Gunaseelan Karunanithi","doi":"10.25259/IJPC_146_2022","DOIUrl":"10.25259/IJPC_146_2022","url":null,"abstract":"<p><strong>Objectives: </strong>The purpose of this study was to map ongoing palliative care services and describe the characteristics of providers, recipients, level of care, and approach. Second, it seeks to investigate the difficulties encountered in implementing NPPC in the Puducherry district of UT Puducherry. This study aims to review the challenges in its implementation.</p><p><strong>Material and methods: </strong>The study using both quantitative and qualitative design, including geospatial mapping of organisations, describing service delivery characteristics and exploring challenges faced in implementing NPPC, was conducted from July 2021 to January 2022. In-depth interviews were conducted with seven healthcare providers, four patients and three caregivers, as well as key informant interviews with six doctors in administration.</p><p><strong>Results: </strong>Thirteen organisations providing palliative care to population of Puducherry district of union territory Puducherry and neighbouring districts of Tamil Nadu were identified. Mapped organisations were primarily concentrated in urban areas. Morphine was available only at three medical colleges, providing outpatient palliative care services. Non-governmental organisations provided only home-based palliative care services and the hospices provided both in-patient and home-based services. Key barriers perceived by the health system were difficulty in procuring morphine, inadequate personnel and inadequate funding. Few barriers perceived by patients/family were stigma faced in community, psychological challenges and poor quality of care.</p><p><strong>Conclusions: </strong>Palliative care services are mainly available in urban areas and through private hospices. There is a need to implement palliative care program through the public health system to improve the accessibility in the rural areas.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/52/6b/IJPC-29-266.PMC10493682.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10232129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prolonged Indwelling Percutaneous Nephrostomy Leading to Purple Urinary Bag Syndrome in Palliative Care Setting: A Case Report. 姑息治疗环境中长期留置经皮肾造口术导致紫色尿袋综合征:一例报告。
IF 1.1 Q3 Medicine Pub Date : 2023-07-01 Epub Date: 2023-07-25 DOI: 10.25259/IJPC_162_2022
Divya Sai Vanumu, Shyam Prasad Mantha, Praneeth Suvvari, Praveen Kumar Kodisharapu

Purple urine bag syndrome (PUBS) is a complication and a rare phenomenon associated with bacterial colonisation in bladder catheters in which urine turns purple in the tubing and the catheter bag. This condition can be distressing and panicking for the patients and their families as well as the medical staff caring for them. It is an interesting and unusual presentation that affects people with long-term indwelling catheters and chronic constipation. We report one such case in our hospital, a 73-year-old woman with stage 4 cancer of the vaginal vault, post-bilateral percutaneous nephrostomy (PCN) 4 months ago, currently on best supportive care, presented to the emergency room with symptoms of urosepsis, while a purple urine bag may appear innocuous and not need any particular care beyond replacing the catheter and giving the patient the proper antibiotics, it may indicate an occult urinary tract infection (UTI), which can have catastrophic effects in a patient using a urinary catheter for an extended period of time. Only a few examples of PUBS with an underlying nephrostomy have been documented in the literature. This is a case of a palliative care patient who had a poor prognosis despite receiving the right antibiotic treatment for an upper UTI that caused purple staining of the PCN catheter bag. Using this case report as a guide, we could manage a complex UTI in a palliative care context.

紫色尿袋综合征(PUBS)是一种并发症,也是一种罕见的与膀胱导管中细菌定植有关的现象,其中尿液在导管和导管袋中变为紫色。这种情况可能会让患者及其家人以及照顾他们的医护人员感到痛苦和恐慌。这是一个有趣而不寻常的表现,影响了长期留置导管和慢性便秘的人。我们在我院报告了一例这样的病例,一名73岁的女性,阴道窦癌症4期,4个月前双侧经皮肾造瘘术(PCN)后,目前正在接受最好的支持性护理,因尿脓毒症症状出现在急诊室,虽然紫色尿袋可能看起来无害,除了更换导尿管和给患者服用适当的抗生素外,不需要任何特别的护理,但它可能表明存在隐性尿路感染(UTI),这可能会对长期使用导尿管的患者产生灾难性影响。文献中只记录了一些潜在肾造瘘的PUBS病例。这是一例姑息治疗患者,尽管对导致PCN导管袋紫色染色的上尿路感染进行了正确的抗生素治疗,但预后不佳。以这份病例报告为指导,我们可以在姑息治疗的背景下处理复杂的尿路感染。
{"title":"Prolonged Indwelling Percutaneous Nephrostomy Leading to Purple Urinary Bag Syndrome in Palliative Care Setting: A Case Report.","authors":"Divya Sai Vanumu,&nbsp;Shyam Prasad Mantha,&nbsp;Praneeth Suvvari,&nbsp;Praveen Kumar Kodisharapu","doi":"10.25259/IJPC_162_2022","DOIUrl":"10.25259/IJPC_162_2022","url":null,"abstract":"<p><p>Purple urine bag syndrome (PUBS) is a complication and a rare phenomenon associated with bacterial colonisation in bladder catheters in which urine turns purple in the tubing and the catheter bag. This condition can be distressing and panicking for the patients and their families as well as the medical staff caring for them. It is an interesting and unusual presentation that affects people with long-term indwelling catheters and chronic constipation. We report one such case in our hospital, a 73-year-old woman with stage 4 cancer of the vaginal vault, post-bilateral percutaneous nephrostomy (PCN) 4 months ago, currently on best supportive care, presented to the emergency room with symptoms of urosepsis, while a purple urine bag may appear innocuous and not need any particular care beyond replacing the catheter and giving the patient the proper antibiotics, it may indicate an occult urinary tract infection (UTI), which can have catastrophic effects in a patient using a urinary catheter for an extended period of time. Only a few examples of PUBS with an underlying nephrostomy have been documented in the literature. This is a case of a palliative care patient who had a poor prognosis despite receiving the right antibiotic treatment for an upper UTI that caused purple staining of the PCN catheter bag. Using this case report as a guide, we could manage a complex UTI in a palliative care context.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ea/28/IJPC-29-324.PMC10493687.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10239163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Science to Spirituality in Paediatric Palliative Care: A Commentary. 儿科姑息治疗中的精神科学:述评。
IF 1.1 Q3 Medicine Pub Date : 2023-07-01 Epub Date: 2023-09-02 DOI: 10.25259/IJPC_48_2023
R R Pravin

Spirituality in paediatric palliative care remains an enigma across both the Eastern and Western worlds. There is no absolute science to it, and it can be a barrier to effective palliative care to be delivered. This article aims to discuss the barriers to and recommendations for discussing this sensitive topic with children and their families to enhance the quality of palliative care rendered, with the aid of case studies to illustrate the underestimated importance of spirituality in paediatric palliative care.

在东西方世界,儿科姑息治疗的精神仍然是一个谜。它没有绝对的科学依据,它可能是提供有效姑息治疗的障碍。本文旨在讨论与儿童及其家人讨论这一敏感话题的障碍和建议,以提高姑息治疗的质量,并借助案例研究来说明精神在儿科姑息治疗中被低估的重要性。
{"title":"The Science to Spirituality in Paediatric Palliative Care: A Commentary.","authors":"R R Pravin","doi":"10.25259/IJPC_48_2023","DOIUrl":"10.25259/IJPC_48_2023","url":null,"abstract":"<p><p>Spirituality in paediatric palliative care remains an enigma across both the Eastern and Western worlds. There is no absolute science to it, and it can be a barrier to effective palliative care to be delivered. This article aims to discuss the barriers to and recommendations for discussing this sensitive topic with children and their families to enhance the quality of palliative care rendered, with the aid of case studies to illustrate the underestimated importance of spirituality in paediatric palliative care.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/78/9d/IJPC-29-336.PMC10493681.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10239167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of Care Pathway for Assessment and Treatment of Fatigue in Palliative Care. 姑息治疗中疲劳评估和治疗护理途径的开发。
IF 1.1 Q3 Medicine Pub Date : 2023-07-01 Epub Date: 2023-01-11 DOI: 10.25259/IJPC_194_2022
Mochamat Mochamat, Marta Przyborek, Birgit Jaspers, Henning Cuhls, Rupert Conrad, Martin Mücke, Lukas Radbruch

Objectives: Fatigue is a frequent and burdensome symptom in patients with advanced disease in palliative care. However, it is under-assessed and undertreated in clinical practice, even though many treatment options have been identified in systematic reviews. Care pathways with defined and standardised steps have been recommended for effective management in the clinical setting. This paper describes a care pathway for managing fatigue in palliative care patients. This study aims to develop a care pathway with detailed guidance for screening, assessment, diagnosis, and treatment of fatigue in palliative care patients.

Material and methods: A collaborative effort of multidisciplinary clinicians participated in constructing the care pathway. The care pathway was developed using the following steps: (a) Developing an intervention; (b) piloting and feasibility; (c) evaluating the intervention; (d) reporting; and (e) implementation. This paper covers the first step, which includes the evidence base identification, theory identification/development, and process/outcomes modeling. A literature search was conducted to understand the extent of the fatigue problem in the palliative care setting and identify existing guidelines and strategies for managing fatigue. Consistent recommendations emanating from the included papers were then contributed to a care pathway. Patient representatives and palliative care professionals provided feedback on the draft.

Results: The care pathway address the following care processes: (1) Screening for the presence of fatigue; (2) assessment to evaluate the severity of fatigue; (3) diagnostic procedure, including history, physical examination, and laboratory finding; (4) therapeutic management pathway for clinical decision-making; and (5) valuation of treatment effect, using questionnaires, diaries and physical activity monitoring with body-worn sensors.

Conclusion: The development of a care pathway will help to implement regular and structured assessment, diagnosis, and treatment of fatigue for healthcare professionals treating palliative care patients. Reviewing the pathway with a multidisciplinary expert group and field testing the pathway will be the next steps toward implementation.

目的:在姑息治疗中,疲劳是晚期疾病患者常见且负担沉重的症状。然而,尽管在系统综述中已经确定了许多治疗方案,但在临床实践中,它的评估不足,治疗不足。建议采用具有明确和标准化步骤的护理途径,以便在临床环境中进行有效管理。本文描述了一种治疗姑息治疗患者疲劳的护理途径。本研究旨在开发一种护理途径,为姑息治疗患者的疲劳筛查、评估、诊断和治疗提供详细指导。材料和方法:多学科临床医生共同努力,参与构建护理路径。护理途径是通过以下步骤制定的:(a)制定干预措施;(b) 试点和可行性;(c) 评估干预措施;(d) 报告;以及(e)执行。本文涵盖了第一步,包括证据库识别、理论识别/开发和过程/结果建模。进行了文献检索,以了解姑息治疗环境中疲劳问题的严重程度,并确定现有的疲劳管理指南和策略。随后,纳入的论文中提出的一致建议被纳入护理途径。患者代表和姑息治疗专业人员对草案提供了反馈意见。结果:护理途径涉及以下护理过程:(1)筛查疲劳的存在;(2) 评估疲劳的严重程度;(3) 诊断程序,包括病史、体格检查和实验室发现;(4) 临床决策的治疗管理途径;以及(5)使用问卷、日记和佩戴传感器的身体活动监测来评估治疗效果。结论:护理途径的开发将有助于为治疗姑息治疗患者的医护人员实施定期和结构化的疲劳评估、诊断和治疗。与多学科专家组一起审查该途径,并对该途径进行实地测试,这将是实施的下一步。
{"title":"Development of Care Pathway for Assessment and Treatment of Fatigue in Palliative Care.","authors":"Mochamat Mochamat,&nbsp;Marta Przyborek,&nbsp;Birgit Jaspers,&nbsp;Henning Cuhls,&nbsp;Rupert Conrad,&nbsp;Martin Mücke,&nbsp;Lukas Radbruch","doi":"10.25259/IJPC_194_2022","DOIUrl":"10.25259/IJPC_194_2022","url":null,"abstract":"<p><strong>Objectives: </strong>Fatigue is a frequent and burdensome symptom in patients with advanced disease in palliative care. However, it is under-assessed and undertreated in clinical practice, even though many treatment options have been identified in systematic reviews. Care pathways with defined and standardised steps have been recommended for effective management in the clinical setting. This paper describes a care pathway for managing fatigue in palliative care patients. This study aims to develop a care pathway with detailed guidance for screening, assessment, diagnosis, and treatment of fatigue in palliative care patients.</p><p><strong>Material and methods: </strong>A collaborative effort of multidisciplinary clinicians participated in constructing the care pathway. The care pathway was developed using the following steps: (a) Developing an intervention; (b) piloting and feasibility; (c) evaluating the intervention; (d) reporting; and (e) implementation. This paper covers the first step, which includes the evidence base identification, theory identification/development, and process/outcomes modeling. A literature search was conducted to understand the extent of the fatigue problem in the palliative care setting and identify existing guidelines and strategies for managing fatigue. Consistent recommendations emanating from the included papers were then contributed to a care pathway. Patient representatives and palliative care professionals provided feedback on the draft.</p><p><strong>Results: </strong>The care pathway address the following care processes: (1) Screening for the presence of fatigue; (2) assessment to evaluate the severity of fatigue; (3) diagnostic procedure, including history, physical examination, and laboratory finding; (4) therapeutic management pathway for clinical decision-making; and (5) valuation of treatment effect, using questionnaires, diaries and physical activity monitoring with body-worn sensors.</p><p><strong>Conclusion: </strong>The development of a care pathway will help to implement regular and structured assessment, diagnosis, and treatment of fatigue for healthcare professionals treating palliative care patients. Reviewing the pathway with a multidisciplinary expert group and field testing the pathway will be the next steps toward implementation.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e3/f1/IJPC-29-256.PMC10493685.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10244005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bleeding Control in Advanced Gastric Cancer; Role of Radiotherapy. 晚期癌症出血控制;放射治疗的作用。
IF 1.1 Q3 Medicine Pub Date : 2023-07-01 Epub Date: 2023-06-12 DOI: 10.25259/IJPC_1_2023
Asifa Andleeb, Kaneez Fatima, Shahida Nasreen, Mushtaq Ahmad Sofi, Arshad Manzoor Najmi, Sumaira Qadri, Farhana Siraj

Objectives: The aim of our study is to see the efficacy of palliative radiotherapy (RT) for bleeding control in patients with advanced gastric cancer (AGC).

Materials and methods: It is a retrospective review based on observations of 74 AGC patients with a median age of 60 years (range 50-82 years) who had active tumour bleeding and were treated with palliative RT. Treatment response was assessed by both subjective symptom relief and objective change in parameters. Objective response to RT was defined by an increase in the median haemoglobin (Hb) level of patients and a decrease in number of packed red blood cell (RBC) units needed by patients after RT.

Results: Response to haemostatic RT was observed in 52 patients out of 74 patients (70.27%). We observed a significant increase in mean Hb level after palliative RT. Pre-RT mean Hb was 6.14 ± 1.01 and post-RT mean Hb was 7.19 ± 1.75 (P < 0.05). Response to RT was also evident in a significant decrease in the number of packed RBC units post-haemostatic RT. The mean number of pre-RT transfused packed RBC units was 8.28 ± 3.76 and post-RT, it was 4.34 ± 2.91 (P < 0.05). The median overall survival was 90 days and the median transfusion-free survival was 40 days.

Conclusion: RT may be an effective treatment option for bleeding control in AGC. In our study, we observed fair and reasonably durable haemostasis. A success rate of 70.24% was documented with clinical palliation, a higher Hb level and fewer transfusions after RT. This modality for bleeding control is more important and reliable in situations where alternative modalities are not feasible.

目的:我们研究的目的是观察姑息性放疗(RT)对晚期癌症(AGC)患者出血控制的疗效。材料和方法:这是一项回顾性综述,基于对74例中位年龄60岁(50-82岁)的AGC患者的观察,这些患者患有活动性肿瘤出血,并接受了姑息性RT治疗。通过主观症状缓解和客观参数变化来评估治疗反应。对RT的客观反应是指患者的中位血红蛋白(Hb)水平增加,RT后患者所需的红细胞(RBC)单位数量减少。结果:74名患者中有52名(70.27%)对止血RT有反应。我们观察到姑息性RT后平均Hb水平显著增加。RT前平均血红蛋白为6.14±1.01,RT后平均血红蛋白为7.19±1.75(P<0.05)。对RT的反应也明显表现为止血RT后填充的红细胞单位数量显著减少。RT前输注的填充红细胞单位的平均数量为8.28±3.76,中位总生存期90天,中位无输血生存期40天。结论:RT可能是控制AGC出血的有效治疗方案。在我们的研究中,我们观察到了公平和合理持久的止血。临床缓解、较高的Hb水平和RT后较少的输血记录了70.24%的成功率。在替代模式不可行的情况下,这种出血控制模式更重要、更可靠。
{"title":"Bleeding Control in Advanced Gastric Cancer; Role of Radiotherapy.","authors":"Asifa Andleeb,&nbsp;Kaneez Fatima,&nbsp;Shahida Nasreen,&nbsp;Mushtaq Ahmad Sofi,&nbsp;Arshad Manzoor Najmi,&nbsp;Sumaira Qadri,&nbsp;Farhana Siraj","doi":"10.25259/IJPC_1_2023","DOIUrl":"10.25259/IJPC_1_2023","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of our study is to see the efficacy of palliative radiotherapy (RT) for bleeding control in patients with advanced gastric cancer (AGC).</p><p><strong>Materials and methods: </strong>It is a retrospective review based on observations of 74 AGC patients with a median age of 60 years (range 50-82 years) who had active tumour bleeding and were treated with palliative RT. Treatment response was assessed by both subjective symptom relief and objective change in parameters. Objective response to RT was defined by an increase in the median haemoglobin (Hb) level of patients and a decrease in number of packed red blood cell (RBC) units needed by patients after RT.</p><p><strong>Results: </strong>Response to haemostatic RT was observed in 52 patients out of 74 patients (70.27%). We observed a significant increase in mean Hb level after palliative RT. Pre-RT mean Hb was 6.14 ± 1.01 and post-RT mean Hb was 7.19 ± 1.75 (<i>P</i> < 0.05). Response to RT was also evident in a significant decrease in the number of packed RBC units post-haemostatic RT. The mean number of pre-RT transfused packed RBC units was 8.28 ± 3.76 and post-RT, it was 4.34 ± 2.91 (P < 0.05). The median overall survival was 90 days and the median transfusion-free survival was 40 days.</p><p><strong>Conclusion: </strong>RT may be an effective treatment option for bleeding control in AGC. In our study, we observed fair and reasonably durable haemostasis. A success rate of 70.24% was documented with clinical palliation, a higher Hb level and fewer transfusions after RT. This modality for bleeding control is more important and reliable in situations where alternative modalities are not feasible.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/54/f1/IJPC-29-279.PMC10493693.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10232131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Multimodal Properties of Quercetin in Chronic Pain Syndromes. 槲皮素在慢性疼痛综合征中的多模式特性。
IF 1.1 Q3 Medicine Pub Date : 2023-07-01 Epub Date: 2023-07-11 DOI: 10.25259/IJPC_151_2022
Abhijit Nair
To the Editor, Bioflavonoids are a family of polyphenolic molecules found in a variety of plants and reportedly have significant antioxidant and anti-inflammatory properties. Based on their chemical structure, flavonoids are broadly classified as flavones, isoflavones, flavanones, flavonols, flavan-3-ols (flavanols), and anthocyanins. Despite the difference in their chemical structure, the members of the flavonoid family share the same flavan nucleus. The recent interest in flavonoids for exploring their role in various chronic ailments is probably their antiinflammatory and anti-oxidative properties mediated through various target molecules. Various flavonoid-containing products are available and marketed for topical and oral use. Flavonoids available in natural sources are subject to variable bioavailability when taken orally. To increase its oral bioavailability and water solubility, companies have introduced these formulations as microcapsules, nanoparticles, liposomes, cyclodextrin, and phospholipid inclusion complexes.[1] Quercetin (3,3′,4′,5,7-pentahydroxyflavone) is a flavonol that is the most common flavonoid which has been investigated in various pathologies in human and animal studies [Figure 1]. Quercetin is a member of bioflavonoids and is found in red wine, green tea and onions. It possesses potent free oxygen scavenging, antioxidant and anti-inflammatory properties. As an antioxidant, quercetin scavenges free radicals directly, chelates metal ions and inhibits lipid peroxidation. The antioxidant property demonstrated an increase if the concentration of quercetin used is more. Research has also demonstrated the anti-tumour properties of quercetin by preventing the cell cycle, promoting cell apoptosis and inhibiting angiogenesis.[2-4] Chemotherapy-induced peripheral neuropathy is a distressing condition that is difficult to manage. The use of quercetin provided favourable results in patients with platinum compounds and taxon-induced peripheral neuropathy in induced models and animal studies.[5] Several human and animal studies investigated the role of quercetin supplements in painful arthritis such as osteoarthritis and rheumatoid arthritis successfully. The plausible mechanisms responsible are cyclo-oxygenase 2 inhibition, reduction of tumour necrosis factor α, interleukin 1β and17, and monocyte chemoattractant protein-1 levels.[6] The neuropathic pain associated with diabetic neuropathy is difficult to treat even with a combination of medications. Flavonoid compounds could be the next possible agent which could relieve the suffering of these patients incessantly suffering from excruciating pain. The regular use of flavonoids has been shown to decrease the reactive oxygen species level by increasing the level of antioxidative enzymes such as glutathione peroxidase, reduced glutathione peroxidase and superoxide dismutase, glutathione reductase and catalase in various tissues such as the liver, sciatic nerve and brain of experimental
{"title":"The Multimodal Properties of Quercetin in Chronic Pain Syndromes.","authors":"Abhijit Nair","doi":"10.25259/IJPC_151_2022","DOIUrl":"10.25259/IJPC_151_2022","url":null,"abstract":"To the Editor, Bioflavonoids are a family of polyphenolic molecules found in a variety of plants and reportedly have significant antioxidant and anti-inflammatory properties. Based on their chemical structure, flavonoids are broadly classified as flavones, isoflavones, flavanones, flavonols, flavan-3-ols (flavanols), and anthocyanins. Despite the difference in their chemical structure, the members of the flavonoid family share the same flavan nucleus. The recent interest in flavonoids for exploring their role in various chronic ailments is probably their antiinflammatory and anti-oxidative properties mediated through various target molecules. Various flavonoid-containing products are available and marketed for topical and oral use. Flavonoids available in natural sources are subject to variable bioavailability when taken orally. To increase its oral bioavailability and water solubility, companies have introduced these formulations as microcapsules, nanoparticles, liposomes, cyclodextrin, and phospholipid inclusion complexes.[1] Quercetin (3,3′,4′,5,7-pentahydroxyflavone) is a flavonol that is the most common flavonoid which has been investigated in various pathologies in human and animal studies [Figure 1]. Quercetin is a member of bioflavonoids and is found in red wine, green tea and onions. It possesses potent free oxygen scavenging, antioxidant and anti-inflammatory properties. As an antioxidant, quercetin scavenges free radicals directly, chelates metal ions and inhibits lipid peroxidation. The antioxidant property demonstrated an increase if the concentration of quercetin used is more. Research has also demonstrated the anti-tumour properties of quercetin by preventing the cell cycle, promoting cell apoptosis and inhibiting angiogenesis.[2-4] Chemotherapy-induced peripheral neuropathy is a distressing condition that is difficult to manage. The use of quercetin provided favourable results in patients with platinum compounds and taxon-induced peripheral neuropathy in induced models and animal studies.[5] Several human and animal studies investigated the role of quercetin supplements in painful arthritis such as osteoarthritis and rheumatoid arthritis successfully. The plausible mechanisms responsible are cyclo-oxygenase 2 inhibition, reduction of tumour necrosis factor α, interleukin 1β and17, and monocyte chemoattractant protein-1 levels.[6] The neuropathic pain associated with diabetic neuropathy is difficult to treat even with a combination of medications. Flavonoid compounds could be the next possible agent which could relieve the suffering of these patients incessantly suffering from excruciating pain. The regular use of flavonoids has been shown to decrease the reactive oxygen species level by increasing the level of antioxidative enzymes such as glutathione peroxidase, reduced glutathione peroxidase and superoxide dismutase, glutathione reductase and catalase in various tissues such as the liver, sciatic nerve and brain of experimental ","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6b/cd/IJPC-29-334.PMC10493683.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10244002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: Addendum: Looking Ahead: Assured of a Vibrant Indian Association of Palliative Care to Lead the World of Palliative Care. 勘误表:附录:展望未来:确保建立一个充满活力的印度姑息治疗协会,领导姑息治疗世界。
IF 1.1 Q3 Medicine Pub Date : 2023-07-01 Epub Date: 2023-09-02 DOI: 10.25259/IJPC_149_2022_ER

[This corrects the article DOI: 10.25259/IJPC_149_2022.].

[这更正了文章DOI:10.25259/IJPC_149_2022.]。
{"title":"Erratum: Addendum: Looking Ahead: Assured of a Vibrant Indian Association of Palliative Care to Lead the World of Palliative Care.","authors":"","doi":"10.25259/IJPC_149_2022_ER","DOIUrl":"10.25259/IJPC_149_2022_ER","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.25259/IJPC_149_2022.].</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/30/67/IJPC-29-341.PMC10493688.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10232127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Palliative Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1